XML 64 R54.htm IDEA: XBRL DOCUMENT v3.8.0.1
Supplemental Condensed Consolidating Financial Information and Other Collateral-Related Information - Schedule of Condensed Consolidating Statement of Cash Flows (Detail) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:        
Net income (loss) $ 530 $ 745 $ 2,102 $ 2,347
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (3,393) (2,546)
Provision for doubtful accounts 1,271 840 3,104 2,392
Depreciation and amortization 539 495 1,581 1,463
Income taxes     (9) 8
Gains on sales of facilities (7) (3) (10) (8)
Losses on retirement of debt 39 4 39 4
Legal claim costs   11   33
Amortization of debt issuance costs     23 26
Share-based compensation     195 196
Other     60 39
Net cash provided by (used in) operating activities     3,692 3,954
Cash flows from investing activities:        
Purchase of property and equipment     (2,033) (1,884)
Acquisition of hospitals and health care entities     (1,142) (468)
Disposition of hospitals and health care entities     24 23
Change in investments     (15) 78
Other     (6) 17
Net cash used in investing activities     (3,172) (2,234)
Cash flows from financing activities:        
Issuance of long-term debt     1,502 5,400
Net change in revolving credit facilities     650 (70)
Repayment of long-term debt     (700) (4,424)
Distributions to noncontrolling interests     (363) (342)
Payment of debt issuance costs     (25) (40)
Repurchases of common stock     (1,475) (2,213)
Other     (37) (95)
Net cash (used in) provided by financing activities     (448) (1,784)
Change in cash and cash equivalents     72 (64)
Cash and cash equivalents at beginning of period     646 741
Cash and cash equivalents at end of period 718 677 718 677
Eliminations [Member]        
Cash flows from operating activities:        
Net income (loss) (436) (573) (1,702) (1,843)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Equity in earnings of affiliates     1,702 1,843
HCA Healthcare, Inc. Issuer [Member]        
Cash flows from operating activities:        
Net income (loss) 426 618 1,742 1,970
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (15) (40)
Income taxes     (9) 8
Equity in earnings of affiliates     (1,702) (1,843)
Other     58 53
Net cash provided by (used in) operating activities     74 148
Cash flows from financing activities:        
Repurchases of common stock     (1,475) (2,213)
Changes in intercompany balances with affiliates, net     1,468 2,171
Other     (66) (105)
Net cash (used in) provided by financing activities     (73) (147)
Change in cash and cash equivalents     1 1
Cash and cash equivalents at end of period 1 1 1 1
HCA Inc. Issuer [Member]        
Cash flows from operating activities:        
Net income (loss) (524) (458) (1,463) (1,305)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (293) (49)
Losses on retirement of debt 39 4 39 4
Legal claim costs   11   33
Amortization of debt issuance costs     23 26
Net cash provided by (used in) operating activities     (1,694) (1,291)
Cash flows from financing activities:        
Issuance of long-term debt     1,500 5,400
Net change in revolving credit facilities     650 (70)
Repayment of long-term debt     (604) (4,334)
Payment of debt issuance costs     (25) (40)
Changes in intercompany balances with affiliates, net     173 335
Net cash (used in) provided by financing activities     1,694 1,291
Subsidiary Guarantors [Member]        
Cash flows from operating activities:        
Net income (loss) 811 788 2,541 2,371
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (1,785) (1,628)
Provision for doubtful accounts 636 391 1,648 1,383
Depreciation and amortization 249 242 748 707
Gains on sales of facilities (4)   (5)  
Share-based compensation     195 196
Other       (3)
Net cash provided by (used in) operating activities     3,342 3,026
Cash flows from investing activities:        
Purchase of property and equipment     (912) (892)
Acquisition of hospitals and health care entities     (9) (164)
Disposition of hospitals and health care entities     12 10
Change in investments       (2)
Other     (2)  
Net cash used in investing activities     (911) (1,048)
Cash flows from financing activities:        
Repayment of long-term debt     (52) (54)
Distributions to noncontrolling interests     (105) (46)
Changes in intercompany balances with affiliates, net     (2,267) (1,895)
Net cash (used in) provided by financing activities     (2,424) (1,995)
Change in cash and cash equivalents     7 (17)
Cash and cash equivalents at beginning of period     110 155
Cash and cash equivalents at end of period 117 138 117 138
Subsidiary Non-Guarantors [Member]        
Cash flows from operating activities:        
Net income (loss) 253 370 984 1,154
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:        
Changes in operating assets and liabilities     (1,300) (829)
Provision for doubtful accounts 635 449 1,456 1,009
Depreciation and amortization 290 253 833 756
Gains on sales of facilities (3) (3) (5) (8)
Other     2 (11)
Net cash provided by (used in) operating activities     1,970 2,071
Cash flows from investing activities:        
Purchase of property and equipment     (1,121) (992)
Acquisition of hospitals and health care entities     (1,133) (304)
Disposition of hospitals and health care entities     12 13
Change in investments     (15) 80
Other     (4) 17
Net cash used in investing activities     (2,261) (1,186)
Cash flows from financing activities:        
Issuance of long-term debt     2  
Repayment of long-term debt     (44) (36)
Distributions to noncontrolling interests     (258) (296)
Changes in intercompany balances with affiliates, net     626 (611)
Other     29 10
Net cash (used in) provided by financing activities     355 (933)
Change in cash and cash equivalents     64 (48)
Cash and cash equivalents at beginning of period     536 586
Cash and cash equivalents at end of period $ 600 $ 538 $ 600 $ 538